142 related articles for article (PubMed ID: 37965956)
1. Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial.
Rasaei N; Malekmakan L; Gholamabbas G; Abdizadeh P
Exp Clin Transplant; 2023 Oct; 21(10):814-819. PubMed ID: 37965956
[TBL] [Abstract][Full Text] [Related]
2. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
5. Treatment of BK Polyomavirus-Associated Nephropathy in Paediatric Kidney Transplant Recipients: Leflunomide Versus Cidofovir.
Kaya Aksoy G; Erkan M; Koyun M; Çomak E; Toru HS; Mutlu D; Akkaya B; Akman S
Exp Clin Transplant; 2024 Jan; 22(1):29-34. PubMed ID: 38149668
[TBL] [Abstract][Full Text] [Related]
6. Effect of Leflunomide on Treatment of Pediatric Renal Transplant Recipients With BK Virus Infection.
Gole E; Mitsioni A; Darema M; Malakasioti G; Askiti V
Exp Clin Transplant; 2023 Oct; 21(10):826-830. PubMed ID: 37965958
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mTOR Inhibitors and Intravenous Immunoglobulin for Treatment of Polyoma BK Nephropathy in Kidney Transplant Recipients: A Biopsy-Proven Study.
Karatas M; Tatar E; Okut G; Yildirim AM; Kocabas E; Tasli Alkan F; Simsek C; Dogan SM; Uslu A
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):118-127. PubMed ID: 38385385
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
[TBL] [Abstract][Full Text] [Related]
9. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
10. [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].
Materne C; Gerth J; Ott U; Gröne HJ; Wolf G
Med Klin (Munich); 2009 Aug; 104(8):644-8. PubMed ID: 19701735
[TBL] [Abstract][Full Text] [Related]
11. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
12. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
14. [BK virus infections in kidney transplantation].
Lanot A; Bouvier N; Chatelet V; Dina J; Béchade C; Ficheux M; Henri P; Lobbedez T; Hurault de Ligny B
Nephrol Ther; 2016 Apr; 12(2):76-85. PubMed ID: 26827190
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.
Jung YH; Moon KC; Ha JW; Kim SJ; Ha IS; Cheong HI; Kang HG
Pediatr Transplant; 2013 Mar; 17(2):E50-4. PubMed ID: 23210794
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.
Araya CE; Garin EH; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2010 Feb; 14(1):145-50. PubMed ID: 19344337
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
18. A single-center experience with BK virus nephropathy.
Ott U; Steiner T; Busch M; Gerth J; Wolf G
Clin Nephrol; 2008 Apr; 69(4):244-50. PubMed ID: 18397698
[TBL] [Abstract][Full Text] [Related]
19. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
